Asia-Pacific
The parties have agreed on a court-guided settlement covering Pantech’s entire SEP portfolio, marking a global first
The Australian side, in particular, can benefit by capitalising on its independent status to bring in more work from Western countries while still working with its former Chinese partner
King & Wood Mallesons will break into two entities, 14 years after a merger between a Chinese and an Australian firm created the combined outfit
The association’s Australian group has filed a formal complaint against the choice of venue, citing Dubai as an unsafe environment for the LGBTQIA+ community
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law analyses a ruling that clarifies the scope of patent infringement, territoriality limits, and research exemptions in a cross-border dispute over Pfizer’s pneumococcal vaccine -
Sponsored by Saint Island International Patent & Law OfficesJulia Y M Hung of Saint Island International Patent & Law Offices explains the implications of a ruling confirming that assignees inherit both rights and defects, even in cases involving an unsettled distributorship dispute
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Shakti Priyan Nair of RNA, Technology and IP Attorneys examine how Indian law and recent court rulings have shaped comparative advertising and trademark disparagement in an increasingly competitive marketplace
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law summarises a Korean Supreme Court ruling on when consumer surveys are admissible in trademark litigation and outlines key takeaways for ensuring survey credibility and evidentiary value
-
Sponsored by Liu, Shen & AssociatesGuanyang Yao of Liu, Shen & Associates reviews several Chinese court rulings on standard-essential patent disputes, including Panasonic v Oppo, and the growing judicial focus on mediation and comparable licences over top-down rate setting
-
Sponsored by Wanhuida Intellectual PropertyWu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations involving active ingredients that are chemically reactive
